I can remember when a Chairman`s report was gone over with a fine tooth comb, analysing the words to find any hidden messages. With all the market action it might be time to visit the report for some speculative appeal.
Page 4 (talking about the new platform)
"Despite some obstacles, we are close to realisation of this goal and in fact recent opportunities and achievements have unlocked a much clearer path".
"Despite longer term potential in myriad markets, the present strategy is focussed on three near term opportunities. These are the neurosurgery product in partnership with Carl Zeiss Ag of Germany, the well developed gastrointestinal endoscopy market"
Last I heard the Gastro market wasn`t near term and wouldn`t come before MR and Zeiss. OIL`s business model is to be an OEM to others that want to sell the product. Is it possible that OIL have a possible partner for GI that is too early to announce.
Slide 10 is worth a read and contains this
"Optiscan’s technology has set the standard for those procedures, and has been well differentiated from other variants as the only form of endomicroscopy with supporting Level 1 evidence"
Probably nothing in it however it is something to think about outside the shorters etc etc
Add to My Watchlist
What is My Watchlist?
